645 related articles for article (PubMed ID: 22301498)
41. [Diagnostic value of MDM2 RNA in situ hybridization in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma].
Chen C; He X; Jing WY; Qiu Y; Chen M; Luo TY; Liu XY; Chen HJ; Zhang HY; Bu H
Zhonghua Bing Li Xue Za Zhi; 2022 Mar; 51(3):190-195. PubMed ID: 35249280
[No Abstract] [Full Text] [Related]
42. Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous components: a case report.
Fujii T; Arai T; Sakon M; Sawano S; Momose Y; Ishii K; Miwa S
Int J Clin Exp Pathol; 2013; 6(7):1427-31. PubMed ID: 23826426
[TBL] [Abstract][Full Text] [Related]
43. Hibernoma Mimicking Atypical Lipomatous Tumor: 64 Cases of a Morphologically Distinct Subset.
Al Hmada Y; Schaefer IM; Fletcher CDM
Am J Surg Pathol; 2018 Jul; 42(7):951-957. PubMed ID: 29629919
[TBL] [Abstract][Full Text] [Related]
44. Liposarcomas of the mediastinum.
Suster DI; Suster S
Mediastinum; 2020; 4():27. PubMed ID: 35118295
[TBL] [Abstract][Full Text] [Related]
45. Molecular updates in adipocytic neoplasms
Demicco EG
Semin Diagn Pathol; 2019 Mar; 36(2):85-94. PubMed ID: 30857767
[TBL] [Abstract][Full Text] [Related]
46. Primary dermal pleomorphic liposarcoma: utility of adipophilin and MDM2/CDK4 immunostainings.
Ramírez-Bellver JL; López J; Macías E; Alegría-Landa V; Gimeno I; Pérez-Plaza A; Kutzner H; Requena L
J Cutan Pathol; 2017 Mar; 44(3):283-288. PubMed ID: 27778364
[TBL] [Abstract][Full Text] [Related]
47. Negative MDM2/CDK4 immunoreactivity does not fully exclude MDM2/CDK4 amplification in a subset of atypical lipomatous tumor/ well differentiated liposarcoma.
Machado I; Vargas AC; Maclean F; Llombart-Bosch A
Pathol Res Pract; 2022 Apr; 232():153839. PubMed ID: 35303521
[TBL] [Abstract][Full Text] [Related]
48. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
49. High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 cases.
Ricciotti RW; Baraff AJ; Jour G; Kyriss M; Wu Y; Liu Y; Li SC; Hoch B; Liu YJ
Cancer Genet; 2017 Dec; 218-219():69-80. PubMed ID: 29153098
[TBL] [Abstract][Full Text] [Related]
50. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
[TBL] [Abstract][Full Text] [Related]
51. Well-differentiated liposarcoma associated with benign lipoma.
Hatano H; Morita T; Ogose A; Hotta T; Kobayashi H; Honma K
Anticancer Res; 2004; 24(2C):1039-44. PubMed ID: 15154619
[TBL] [Abstract][Full Text] [Related]
52. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.
Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A
J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942
[TBL] [Abstract][Full Text] [Related]
53. Liposarcoma of the pleural cavity.
Kawai T; Nakashima H; Washimi K; Yokose T; Matsuo T; Nakayama M; Shinohara N; Kuroda H; Ishida K; Akiba J; Ishikawa M; Urabe S; Shiraishi J; Shiraishi T; Sakamoto A; Matsukuma S
Hum Pathol; 2023 Jun; 136():105-113. PubMed ID: 37023867
[TBL] [Abstract][Full Text] [Related]
54. A contemporary review of myxoid adipocytic tumors.
Creytens D
Semin Diagn Pathol; 2019 Mar; 36(2):129-141. PubMed ID: 30853315
[TBL] [Abstract][Full Text] [Related]
55. Fluorescence In Situ Hybridization for MDM2 Amplification as a Routine Ancillary Diagnostic Tool for Suspected Well-Differentiated and Dedifferentiated Liposarcomas: Experience at a Tertiary Center.
Thway K; Wang J; Swansbury J; Min T; Fisher C
Sarcoma; 2015; 2015():812089. PubMed ID: 25810689
[TBL] [Abstract][Full Text] [Related]
56. A subset of fat-predominant angiomyolipomas label for MDM2: a potential diagnostic pitfall.
Asch-Kendrick RJ; Shetty S; Goldblum JR; Sharma R; Epstein JI; Argani P; Cimino-Mathews A
Hum Pathol; 2016 Nov; 57():7-12. PubMed ID: 27369456
[TBL] [Abstract][Full Text] [Related]
57. Tenascin C and cathepsin d expression in adipocytic tumors: an immunohistochemical investigation of 43 cases.
Sis B; Tuna B; Yorukoglu K; Kargi A
Int J Surg Pathol; 2004 Jan; 12(1):11-5. PubMed ID: 14765267
[TBL] [Abstract][Full Text] [Related]
58. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma.
Crago AM; Singer S
Curr Opin Oncol; 2011 Jul; 23(4):373-8. PubMed ID: 21552124
[TBL] [Abstract][Full Text] [Related]
59. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
Wang X; Asmann YW; Erickson-Johnson MR; Oliveira JL; Zhang H; Moura RD; Lazar AJ; Lev D; Bill K; Lloyd RV; Yaszemski MJ; Maran A; Oliveira AM
Genes Chromosomes Cancer; 2011 Nov; 50(11):849-58. PubMed ID: 21793095
[TBL] [Abstract][Full Text] [Related]
60. Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor.
Kashima T; Halai D; Ye H; Hing SN; Delaney D; Pollock R; O'Donnell P; Tirabosco R; Flanagan AM
Mod Pathol; 2012 Oct; 25(10):1384-96. PubMed ID: 22699518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
